Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,206.40
(
0.01%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
100.19
(
-1.00%
)
Bitcoin
77,974.79
(
-0.39%
)
News Focus
News Focus
Post# of 257442
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

n4807g

Send PM Follow Ignore
Followers 42
Posts 33944
Boards Moderated 0
Alias Born 07/08/2003

n4807g

Member Level

Re: joe_techi post# 202437

Thursday, 07/07/2016 9:06:17 PM

Thursday, July 07, 2016 9:06:17 PM

Post# of 257442
My take, the therapies are in the early stage of development with a steep learning curve. I don't believe any of the CAR-T therapies have been used in patient populations in sufficient numbers to determine adverse events and associated risk, therefore, safety profile unknown.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today